Clinical trial investigators and site coordinators
Preparing for an FDA inspection of a clinical trial site
The Clinical Trials mind map template from Xmind is a comprehensive reference for clinical research professionals, covering 187 nodes across 16 major branches including Laws, study protocol, IRB, informed consent, and FDA regulations. It details key documents like Form FDA 1572, the Investigator's Brochure, and NDA new drug application, and highlights critical events such as the Jesse Gelsinger 1999 case. This template serves as a structured cheat sheet for understanding GCP, FDA oversight, and post-drug approval responsibilities, making it an essential study aid for clinical trial coordinators, investigators, and regulatory affairs specialists. The mind map organizes complex regulatory frameworks into digestible sections, with nodes like 'Common GCP violations' listing failure to follow study protocol and informed consent violations, while 'FDA's Animal Efficacy Rule' explains how animal studies can support drug approval when human trials are not feasible.
이용약관Preparing for an FDA inspection of a clinical trial site
Training new staff on Good Clinical Practice (GCP) and regulatory compliance
Developing a new study protocol and ensuring all regulatory requirements are met
Open the template in Xmind to navigate through the sixteen major branches covering laws, protocols, and FDA regulations.
Expand collapsed sub-topics to study specific GCP violations or forms and add your own research notes to personalize the content.
Save your finalized mind map as a PDF or image to use as a structured cheat sheet for clinical research presentations.
The template covers 187 nodes across key topics: Laws (21 CFR, ICH GCP), study protocol, roles of sponsor, IRB, monitor, investigator, informed consent, Investigator's Brochure, Form FDA 1572, 2009 Guidance, FDA Form 483, common GCP violations, Jesse Gelsinger case, Animal Efficacy Rule, NDA, and post-drug approval responsibilities.
Use the 'Common GCP violations' branch to review frequent issues like protocol deviations and informed consent errors. The 'FDA form 483' section explains inspection outcomes (NAI, VAI, OAI). Customize the template by adding your own audit checklist nodes.
Yes, it provides a structured overview of regulatory documents (Form FDA 1572, Investigator's Brochure) and roles (sponsor, monitor, investigator). Trainers can use it as a visual aid to explain the clinical trial lifecycle and compliance requirements.
Yes, the 'Post Drug Approval Respns' branch (abbreviated in the tree) includes FDA oversight after marketing. The template also references NDA goals and Drug Marketing Approval Applications.
Absolutely. Open the .xmind file in Xmind, then modify the 'study protocol' branch to include your study's objectives, design, dosages, and statistical plan. Add new subtopics as needed.
전 세계 크리에이터와 마인드맵 템플릿을 공유하고 작품으로 수익을 창출하세요.